In order to obtain this action we must pay 1,52$ right now, Akari Therapeutics PLC is a company created in United Kingdom dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in Europe. Its Executives are Clive Stuart Richardson (CEO, Chief Operating Officer & Director), Miles Nunn (Chief Scientific Officer), Torsten Hombeck (Chief Financial & Accounting Officer), Wynne Weston-Davies (Medical Director) and its address is 75/76 WIMPOLE STREET, LONDON, W1G 9RT, United Kingdom.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 1,54$ moving between 1,47$ and 1,60$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
